Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Phototherapy can help treat hair loss in alopecia areata.

Dermoscopy helps accurately diagnose and treat benign skin cysts.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Understanding how acne develops in different diseases could lead to new treatments.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Baricitinib is effective for severe alopecia areata but has some side effects.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Chrysanthemum zawadskii extract may be a better treatment for hair loss than Minoxidil.

Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.